TABLE 3.
Freq. | mOD | admOD | 95% CI | P | ||
---|---|---|---|---|---|---|
Demographics | ||||||
Gender | Femaleb | 7 | 0.280 | - | - | - |
Male | 133 | 0.304 | 0.084 | (−0.16–0.24) | .431 | |
Age (yr) | ≤35b | 39 | 0.338 | - | - | - |
35–45 | 65 | 0.276 | 0.070 | (−0.02–0.14) | .121 | |
>45 | 36 | 0.316 | 0.026 | (−0.09–0.12) | .634 | |
Ethnicity | Non-Hb | 80 | 0.269 | - | - | - |
H | 60 | 0.352 | 0.111 | (0.03–0.18) | .012 | |
HIV-related factors | ||||||
CD4 (cells/mm3) | >200b | 103 | 0.278 | - | - | - |
≤200 | 37 | 0.382 | 0.105 | (−0.01–0.19) | .063 | |
CD8 (cells/mm3) | >400b | 121 | 0.295 | - | - | - |
<400 | 18 | 0.330 | 0.034 | (−0.13–0.16) | .640 | |
HIV load (copies/ml) | ≤400b | 71 | 0.285 | - | - | - |
<400 | 68 | 0.321 | 0.056 | (−0.04–0.14) | .245 | |
HIV duration (yr) | ≤15b | 108 | 0.282 | - | - | - |
>15 | 31 | 0.387 | 0.324 | (0.16–0.46) | .001 | |
Other coinfections | ||||||
Syphilis | Nb | 117 | 0.310 | - | - | - |
P | 23 | 0.268 | 0.038 | (−0.08–0.19) | .553 | |
Gonorrhea | Nb | 128 | 0.302 | - | - | - |
P | 12 | 0.307 | 0.061 | (−0.15–0.21) | .524 | |
HPV | Nb | 137 | 0.302 | - | - | - |
P | 3 | 0.320 | 0.021 | (−0.22–0.50) | .901 | |
Chlamydia | Nb | 134 | 0.301 | - | - | - |
P | 6 | 0.335 | 0.085 | (−0.22–0.27) | .514 | |
HSV2 | Nb | 127 | 0.299 | - | - | - |
P | 13 | 0.333 | 0.078 | (−0.12–0.22) | .390 | |
Hepatitis | Nb | 98 | 0.291 | - | - | - |
P | 42 | 0.331 | 0.083 | (−0.04–0.18) | .168 |
Analyses for HIV-related factors and coinfections were adjusted for age and ethnicity.
Reference category.
Abbreviations: mOD, mean optical density; admOD, adjusted difference mean O.D.; CI, confidence interval; Non-H, Non-Hispanics; H, Hispanics; yr, year; N, negative; P, positive; HPV, human papilloma virus; HSV2, herpes simplex virus 2.